Drug profile · INN
tegafur/gimeracil /oteracil potassium
TS-1 PARTIAL CHANGE APPROVAL
tegafur/gimeracil /oteracil potassium (TS-1 PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — tegafur/gimeracil /oteracil potassium
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.78
Quick answer
tegafur/gimeracil /oteracil potassium (TS-1 PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN tegafur/gimeracil /oteracil potassium
Brand TS-1 PARTIAL CHANGE APPROVAL
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is tegafur/gimeracil /oteracil potassium?
tegafur/gimeracil /oteracil potassium (TS-1 PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for tegafur/gimeracil /oteracil potassium?
TS-1 PARTIAL CHANGE APPROVAL is a marketed brand name for tegafur/gimeracil /oteracil potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.